Evolus (EOLS) Shares Outstanding (Weighted Average) (2017 - 2026)

Evolus (EOLS) reported Shares Outstanding (Weighted Average) of $65.2 million for Q1 2026, up 2.34% on a YoY basis from $63.7 million in Q1 2025, and up 1.11% quarter-over-quarter from $64.5 million in Q4 2025.

Evolus (EOLS) Shares Outstanding (Weighted Average) (2017 - 2026) Analysis & Trends

Evolus has reported Shares Outstanding (Weighted Average) for 10 years, with the latest figure at $65.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 2.34% year-over-year to $65.2 million; the trailing twelve-month figure through Mar 2026 stood at $65.2 million (up 2.34% YoY), and the FY2025 full-year result was $64.5 million, up 3.95% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $65.2 million, up from $64.5 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $65.2 million in Q1 2026, with the low at $55.7 million in Q1 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $59.9 million across 5 years, with a median of $58.8 million in 2024.
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) soared 50.22% — and 2023, when it increased 1.34%.
  • Evolus' Shares Outstanding (Weighted Average) stood at $56.1 million in 2022, then increased by 1.52% to $56.9 million in 2023, then gained by 8.96% to $62.0 million in 2024, then climbed by 3.95% to $64.5 million in 2025, then grew by 1.11% to $65.2 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $65.2 million (Q1 2026), $64.5 million (Q4 2025), and $64.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.16 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 166.20 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 64.74 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 228.36 Mn
10 Evolus 435.45 Mn 385.65 Mn 48.90 Mn 65.19 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 65.19 Mn
Dec 31, 2025 64.47 Mn
Sep 30, 2025 64.73 Mn
Jun 30, 2025 64.12 Mn
Mar 31, 2025 63.70 Mn
Dec 31, 2024 62.02 Mn
Sep 30, 2024 61.56 Mn
Jun 30, 2024 62.72 Mn
Mar 31, 2024 58.80 Mn
Dec 31, 2023 56.92 Mn
Sep 30, 2023 57.02 Mn
Jun 30, 2023 56.92 Mn
Mar 31, 2023 56.48 Mn
Dec 31, 2022 56.07 Mn
Sep 30, 2022 56.18 Mn
Jun 30, 2022 55.91 Mn
Mar 31, 2022 55.73 Mn
Dec 31, 2021 49.77 Mn
Sep 30, 2021 47.82 Mn
Jun 30, 2021 44.16 Mn